Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Colombia
Colombia: Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage was 91.0% in 2024. ▲ Rising
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Colombia, 2010–2024
Source: WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data. Measured in %.
Analysis
Colombia recorded 91.0% for pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in 2024.
Compared with earlier readings it is up 1.1% on the previous year and up 2.2% over ten years.
Over the whole period, pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Colombia peaked at 94.0% in 2018 and was at its lowest, 22.0%, in 2010.
That places Colombia 52nd out of 146 countries with data for 2024, putting it in the middle of the range.
The long-run direction has been consistently rising across the 15 years of available data.
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Colombia, year by year
| Year | % | Change |
|---|---|---|
| 2010 | 22.0% | — |
| 2011 | 46.0% | +109.1% |
| 2012 | 84.0% | +82.6% |
| 2013 | 87.0% | +3.6% |
| 2014 | 89.0% | +2.3% |
| 2015 | 91.0% | +2.2% |
| 2016 | 89.0% | -2.2% |
| 2017 | 91.0% | +2.2% |
| 2018 | 94.0% | +3.3% |
| 2019 | 93.0% | -1.1% |
| 2020 | 89.0% | -4.3% |
| 2021 | 84.0% | -5.6% |
| 2022 | 85.0% | +1.2% |
| 2023 | 90.0% | +5.9% |
| 2024 | 91.0% | +1.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 78.6% | 22.0% | 94.0% | 10 |
| 2020s | 87.8% | 84.0% | 91.0% | 5 |
Countries ranked near Colombia
More health data for Colombia
- Un projection of annual infant deaths, annual growth rate -1.83 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.3468 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,505 deaths per 1,000 people (2090)
- Number of infants who die before age 1 698 deaths (2100)
- Population ages 0-14, female, annual growth rate -0.359 % change on previous year (2025)
- Population ages 0-14, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 0-14, female, per capita 0.0979 units per person (2025)
- Population ages 0-14, male, annual growth rate -0.3835 % change on previous year (2025)
- Population ages 0-14, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 0-14, male, per capita 0.102 units per person (2025)
Frequently asked questions
- What is pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Colombia?
- Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Colombia was 91.0% in 2024, according to WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data.
- What is the highest pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage recorded in Colombia?
- The highest recorded value was 94.0% in 2018.
- What is the lowest pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage recorded in Colombia?
- The lowest recorded value was 22.0% in 2010.
- How does Colombia rank for pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage?
- Colombia ranks 52nd out of 146 countries with data for 2024.
- Is pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage rising or falling in Colombia?
- Over the last ten years it is up 2.2%. The long-run trend across the full record is rising.
- Where does this Colombia data come from?
- The figures come from WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as part of Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 15 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Share of one-year-olds who have had the third dose of the pneumococcal conjugate vaccine in a given year.